(Health-NewsWire.Net, May 27, 2017 ) Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression and restlessness, inability to control drinking and violent behavior. Risk factors include age, family history and depression and other mental health problems.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Alcohol Addiction - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Alcohol Addiction (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 3, 10, 1, 1, 16 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 4 and 1 molecules, respectively.
Alcohol Addiction (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
For more information about this report at http://www.reportsweb.com/alcohol-addiction-pipeline-review-h1-2017
Report Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Alcohol Addiction (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Alcohol Addiction (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Alcohol Addiction (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Alcohol Addiction (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Alcohol Addiction (Central Nervous System)
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001689395/sample
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Alcohol Addiction (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Alcohol Addiction (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
AbbVie Inc
Addex Therapeutics Ltd
Adial Pharmaceuticals LLC
Astraea Therapeutics LLC
BioCorRx Inc
Bionex Pharmaceuticals LLC
Bioprojet SCR
Cerecor Inc
Chronos Therapeutics Ltd
Corcept Therapeutics Inc
Curemark LLC
Eli Lilly and Company
Ethypharm SA
Euthymics Bioscience Inc
H. Lundbeck A/S
Heptares Therapeutics Ltd
Indivior Plc
Kinnov Therapeutics SAS
Kyorin Pharmaceutical Co Ltd
Lohocla Research Corp
Omeros Corp
Pfizer Inc
Savant HWP Inc
SK Biopharmaceuticals Co Ltd
Tonix Pharmaceuticals Holding Corp
VM Discovery Inc
XenoPort Inc
Zynerba Pharmaceuticals Inc
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001689395/discount
List of Tables
Number of Products under Development for Alcohol Addiction, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Alcohol Addiction - Pipeline by AbbVie Inc, H1 2017
Alcohol Addiction - Pipeline by Addex Therapeutics Ltd, H1 2017
Alcohol Addiction - Pipeline by Adial Pharmaceuticals LLC, H1 2017
Alcohol Addiction - Pipeline by Astraea Therapeutics LLC, H1 2017
Alcohol Addiction - Pipeline by BioCorRx Inc, H1 2017
Alcohol Addiction - Pipeline by Bionex Pharmaceuticals LLC, H1 2017
Alcohol Addiction - Pipeline by Bioprojet SCR, H1 2017
Alcohol Addiction - Pipeline by Cerecor Inc, H1 2017
Alcohol Addiction - Pipeline by Chronos Therapeutics Ltd, H1 2017
Alcohol Addiction - Pipeline by Corcept Therapeutics Inc, H1 2017
Alcohol Addiction - Pipeline by Curemark LLC, H1 2017
Alcohol Addiction - Pipeline by Eli Lilly and Company, H1 2017
Alcohol Addiction - Pipeline by Ethypharm SA, H1 2017
Alcohol Addiction - Pipeline by Euthymics Bioscience Inc, H1 2017
Alcohol Addiction - Pipeline by H. Lundbeck A/S, H1 2017
Alcohol Addiction - Pipeline by Heptares Therapeutics Ltd, H1 2017
Alcohol Addiction - Pipeline by Indivior Plc, H1 2017
Alcohol Addiction - Pipeline by Kinnov Therapeutics SAS, H1 2017
Alcohol Addiction - Pipeline by Kyorin Pharmaceutical Co Ltd, H1 2017
Alcohol Addiction - Pipeline by Lohocla Research Corp, H1 2017
Alcohol Addiction - Pipeline by Omeros Corp, H1 2017
Alcohol Addiction - Pipeline by Pfizer Inc, H1 2017
Alcohol Addiction - Pipeline by Savant HWP Inc, H1 2017
Alcohol Addiction - Pipeline by SK Biopharmaceuticals Co Ltd, H1 2017
Alcohol Addiction - Pipeline by Tonix Pharmaceuticals Holding Corp, H1 2017
Alcohol Addiction - Pipeline by VM Discovery Inc, H1 2017
Alcohol Addiction - Pipeline by XenoPort Inc, H1 2017
Alcohol Addiction - Pipeline by Zynerba Pharmaceuticals Inc, H1 2017
Alcohol Addiction - Dormant Projects, H1 2017
Alcohol Addiction - Dormant Projects, H1 2017 (Contd...1), H1 2017
Alcohol Addiction - Discontinued Products, H1 2017
Purchase Complete Report at http://www.reportsweb.com/buy&RW0001689395/buy/2000
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|